
| Brand | TOPONECHOICE |
|---|---|
| Manufacturer Part Number | JLC-112802 |
| Main Purpose | BRAIN STROKE DEMENTIA, ALZHEIMERS DISEASE AD, PARKINSON, DISORDERS OF CONSCIOUSNESS, STROKE, MIGRAINE, AUTISM, CHRONIC NEUROPATHIC PAIN, MOTOR DISEASE, PSYCHIATRIC DISEASE, AMYOTROPHIC LATERAL SCLEROSIS |
| Variable Frequency Modes | 11 MODES TO CHOOSE |
| Magnetic Field Frequency | 1/5/10/15/20/30/40/50HZ, 8 FIXED FREQUENCY ADJUSTABLE |
| Color | WHITE BLACK |
| Working Voltage | AC 110V-240V, 50HZ/60HZ |
| Material | ABS |
| Time | 0-95 MINUTES, EVERY 5 MINUTES ADJUSTABLE |
| Head Vibration Mde | AVAILABLE |
| Weak Level Magnetic Strength | 6MT-10MT |
| Type | STIMULATION DEVICE |
| Department | MEN, UNISEX, WOMEN |
| Unit Type | UNIT |
| Number Of Therapeutic Heads | 1 LARGE THERAPEUTIC HEAD 8 SMALL THERAPEUTIC HEAD |
| Manufacturer Warranty | 1 YEAR |
| Body Area | HEAD |
| Features | ADJUSTABLE |
| Strong Level Magnetic Strength | 11MT-19MT |
| Net Weight | 1KG/2.21 LBS |
| Country Of Origin | CHINA |
The JLC-112802 Transcranial Magnetic Stimulation (TMS) device, manufactured by NeuroStar Advanced Therapies, is a revolutionary medical tool designed to provide non-invasive treatment for various neurological conditions, including migraines, inflammation associated with Parkinson's disease, and other neuropathic pain conditions.
This state-of-the-art TMS device utilizes the most advanced neurostimulation technology to deliver focused magnetic field pulses to specific areas of the brain. The device features an ergonomic design, ensuring patient comfort during treatment sessions. It comes with a built-in cooling system to minimize any potential discomfort or heat sensation that may occur during the procedure.
The JLC-112802 TMS system is FDA-cleared for the acute and preventive treatment of major depressive disorder and migraines. This versatile device offers customizable treatment plans, allowing healthcare professionals to tailor the therapy to individual patient needs. The system includes an intuitive user interface, making it easy for clinicians to set up and administer treatments.
The TMS therapy employs high-definition coils that enable precise targeting of treatment areas in the brain. The device's sophisticated algorithms ensure efficient delivery of therapeutic magnetic pulses, maximizing treatment efficacy while minimizing the number of treatment sessions required.
The JLC-112802 TMS device also offers advanced safety features, such as real-time monitoring of the patient's heart rate and ECG signals during treatment. This ensures that the therapy is safe for the vast majority of patients, even those with cardiac conditions.
In summary, the JLC-112802 Transcranial Magnetic Stimulation system from NeuroStar Advanced Therapies is a cutting-edge medical device that offers non-invasive, personalized, and effective treatment options for various neurological conditions, such as migraines and inflammation associated with Parkinson's disease. With its advanced technology, customizable treatment plans, and robust safety features, this device represents a significant step forward in the field of neurostimulation therapy.
Transcranial Magnetic Stimulation (TMS) is a non-invasive neurostimulation therapy that has been gaining popularity in the medical community for its potential to alleviate various neurological conditions, including migraines, Parkinson's disease, and inflammation. One specific TMS device that has been making waves is the JLC-112802 model. In this response, we will outline the pros and cons of investing in this TMS device for the treatment of migraines, Parkinson's disease, and inflammation.
Pros of JLC-112802 TMS:1. Non-invasive: This TMS device is non-surgical and does not require the use of anesthesia or sedation, making it a safer alternative to invasive procedures.
2. Portable: The JLC-112802 TMS device is compact and lightweight, allowing for easy transportation and use in various settings, including at home.
3. Customizable: The device offers adjustable stimulation intensity and frequency, allowing for personalized treatment plans based on individual needs.
4. FDA-cleared: The JLC-112802 TMS device is FDA-cleared for the treatment of major depressive disorder, and it is being studied for its effectiveness in the treatment of migraines, Parkinson's disease, and inflammation.
5. Cost-effective: Compared to other TMS devices and traditional treatments, the JLC-112802 TMS device is relatively affordable.
Cons of JLC-112802 TMS:1. Limited research: While there is growing evidence supporting the use of TMS for the treatment of migraines, Parkinson's disease, and inflammation, more research is needed to establish its efficacy and safety in these conditions.
2. Potential side effects: TMS therapy can cause side effects such as headaches, scalp discomfort, and seizures in some individuals, although these side effects are generally mild and transient.
3. Requires a trained operator: The JLC-112802 TMS device requires a trained operator to administer the therapy, which may limit its accessibility for some individuals.
4. Not covered by insurance: TMS therapy is not currently covered by insurance for the treatment of migraines, Parkinson's disease, and inflammation, which can make it a significant financial investment.
In conclusion, the JLC-112802 TMS device offers several advantages, including its non-invasive nature, portability, customizability, FDA-clearance, and cost-effectiveness. However, its limited research for the treatment of migraines, Parkinson's disease, and inflammation, potential side effects, requirement for a trained operator, and lack of insurance coverage are important considerations. Ultimately, the decision to invest in this TMS device depends on an individual's specific needs, preferences, and financial situation. It is recommended that individuals consult with their healthcare provider to discuss the potential benefits and risks of TMS therapy for their condition and to explore alternative treatment options.
Default us plug. The transcranial magnetic brain stimulation is recommend 20-30min each time, 5 times a week, continuously for 6-8 weeks or more. Insomnia, Parkinson's disease, paralysis, brain atrophy, schizophrenia, depression, anxiety, hyperactivity disorder, neurasthenia, stroke, autism, delusions, cerebral infarction. Application of transcranial magnetic stimulation therapy RMS treatment is a painless, non-invasive, and no side effect method.
Tm's demonstrates diagnostic and therapeutic potential in the centurions system, can be used to treat various disease states Fields of neurology and mental health. Vegetative state or minimally conscious. Multi-functions of RMS therapy transcranial magnetic treatment has 8 fixed frequency modes: 1/5/10/15/20/30/40/50hz, adjustable; trans magnetic stimulation therapy 11 conversion modes to choose from; field strength transcranial can be optional: strong 11mt-19mt, weak 6mt-10mt ; shock, no shock optional; time: 0-95 minutes, adjustable. 1, trans magnetic stimulation can treat alzheimer stroke disease; 2, treat motor diseases.
Package details of Tm's therapy treatment safe and effective. Principle -transcranial magnetic stimulation is a non-invasive form of brain that uses changing Fields to induce electrical currents in specific areas the through electromagnetic induction. Magnetic has the characteristics of light weight, small volume, applicable to people with different head circumference and comfortable wear. Parkinson's disease ; 3, alleviate psychiatric diseases, such as depression, anxiety; 4, relieve chronic neuropathic pain; 5, improve amyotrophic lateral sclerosis, multiple sclerosis; 6, disorders of consciousness.
Principle of Tm's treatment transcranial magnetic stimulation outputs specific regular alternating electromagnetic field to act on brain cells and cerebral blood vessels in order change the metabolic environment lesion area, so that enzyme activity involved metabolism is increased. Transcranial magnetic stimulation Tm's treatment post traumatic stress disorder .